Overview

A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Status:
Terminated

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety profile of voriconazole (an antifungal drug) when used in children who have invasive aspergillosis (IA) and other rare systemic fungal infections.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Voriconazole